pentobarbital will lower the extent or result of voriconazole by influencing hepatic enzyme CYP2C9/10 metabolism. Insignificant/Significance Mysterious.

pentobarbital will lower the extent or outcome of atazanavir by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Importance Unfamiliar.

pentobarbital will lessen the level or outcome of elagolix by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe.

pentobarbital will lessen the level or effect of solifenacin by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.

pentobarbital boosts toxicity of ifosfamide by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of. CYP3A4 inducers may possibly enhance the metabolism of ifosfamide to its active alkylating metabolites.

pentobarbital will lower the level or result of oxybutynin by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unfamiliar.

pentobarbital will lessen the level or outcome of ambrisentan by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Significance Not known.

lasmiditan, pentobarbital. Either boosts effects of the other by sedation. Use Caution/Watch. Coadministration of lasmiditan as well as other CNS depressant drugs, which include Alcoholic beverages have not been evaluated in medical experiments. Lasmiditan could bring about sedation, as well as other cognitive and/or neuropsychiatric adverse reactions.

Observe Carefully (1)pentobarbital will reduce the extent or result of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

pentobarbital will minimize the extent or impact of irinotecan by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe.

pentobarbital will lessen here the level or effect of netupitant/palonosetron by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Steer clear of or Use Alternate Drug. Netupitant is principally metabolized by CYP3A4; steer clear of use in sufferers that are chronically utilizing a robust CYP3A4 inducer

pentobarbital will reduce the level or influence of glecaprevir/pibrentasvir by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

pentobarbital will decrease the level or effect of loratadine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.

pentobarbital will lower the level or influence of dasatinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check.